Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
暂无分享,去创建一个
[1] S. Moestrup,et al. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. , 2010, Immunobiology.
[2] F. Rubino,et al. The Diabetes Surgery Summit Consensus Conference: Recommendations for the Evaluation and Use of Gastrointestinal Surgery to Treat Type 2 Diabetes Mellitus , 2010, Annals of surgery.
[3] E. Moler,et al. Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2010, Diabetes Care.
[4] B. Ludvik,et al. Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist to hip ratio and insulin resistance , 2010, International Journal of Obesity.
[5] David M Nathan,et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.
[6] K. Clément,et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. , 2009, The Journal of clinical endocrinology and metabolism.
[7] C. Buechler,et al. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity , 2009, European journal of clinical investigation.
[8] Torben Hansen,et al. Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.
[9] S. Bojesen,et al. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Gupta,et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. , 2009, The Journal of the Association of Physicians of India.
[11] Børge G Nordestgaard,et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. , 2008, JAMA.
[12] B. Nordestgaard,et al. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. , 2008, Circulation.
[13] William M. Lee,et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. , 2007, Journal of hepatology.
[14] T. Stulnig,et al. Adipose tissue macrophages. , 2007, Immunology letters.
[15] V. Fuster,et al. Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype: Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability , 2007, Circulation research.
[16] G. Zlabinger,et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production , 2007, International Journal of Obesity.
[17] P Zimmet,et al. International Diabetes Federation: a consensus on Type 2 diabetes prevention , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[18] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[19] J. Carrero,et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] S. Moestrup,et al. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163* , 2006, Critical care medicine.
[21] S. Vogel,et al. Pivotal Advance: Activation of cell surface Toll‐like receptors causes shedding of the hemoglobin scavenger receptor CD163 , 2006, Journal of leukocyte biology.
[22] S. Moestrup,et al. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. , 2006, Atherosclerosis.
[23] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[24] M. Kurrer,et al. Soluble hemoglobin–haptoglobin scavenger receptor CD163 as a lineage‐specific marker in the reactive hemophagocytic syndrome , 2005, European journal of haematology.
[25] K. Clément,et al. The FASEB Journal • Research Communication Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects , 2022 .
[26] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[27] S. Moestrup,et al. Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease , 2004, European journal of haematology.
[28] S. Moestrup,et al. CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory response , 2004, Annals of medicine.
[29] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[30] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[31] R. Muniyappa,et al. The diabetes prevention program , 2003, Current diabetes reports.
[32] S. Moestrup,et al. Characterization of an enzyme-linked immunosorbent assay for soluble CD163 , 2002, Scandinavian journal of clinical and laboratory investigation.
[33] S. Moestrup,et al. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. , 2002, Blood.
[34] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[35] S. Neubauer,et al. Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme‐distribution in a model of left ventricular dysfunction , 2001, European journal of heart failure.
[36] P. Schnohr. The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .
[37] R. Collins,et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.
[38] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[39] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[40] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[41] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[42] M. Feinglos,et al. Stress and Diabetes , 1984 .
[43] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.